Search research articles
Contact Us
Filters
Showing results (401-410 of 417) with videos related to
Page
of 42
Sort By:
Diabetes Research and Clinical Practice
|
January 15, 2022
Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study)
Annieke C G van Baar, Jacques Devière, David Hopkins, et al.
Gut
|
June 1, 2019
Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
Pieter de Groot, Torsten Scheithauer, Guido J Bakker, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 14, 2017
Individual and partner's level of occupation and the association with HbA<sub>1c</sub> levels in people with Type 2 diabetes mellitus: the Dutch Diabetes Pearl cohort
A Rutte, S P Rauh, M T Schram, et al.
Drugs - Real World Outcomes
|
March 22, 2022
Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer
Marscha S Holleman, Simone A Huygens, Maiwenn J Al, et al.
Clinical and Translational Gastroenterology
|
May 26, 2018
Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects
Kec Bouter, G J Bakker, E Levin, et al.
Gastroenterology
|
June 26, 2012
Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome
Anne Vrieze, Els Van Nood, Frits Holleman, et al.
Diabetologia
|
January 10, 2020
Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial
Pieter F de Groot, Tatjana Nikolic, Sultan Imangaliyev, et al.
Scientific Reports
|
October 23, 2020
Identifying genetic factors that contribute to the increased risk of congenital heart defects in infants with Down syndrome
Cristina E Trevino, Aaron M Holleman, Holly Corbitt, et al.
Journal of Hepatology
|
December 10, 2013
Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity
Anne Vrieze, Carolien Out, Susana Fuentes, et al.
Gut
|
October 27, 2020
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
Pieter de Groot, Tanja Nikolic, Silvia Pellegrini, et al.
Page
of 42
Search research articles
Search
Showing results (401-410 of 417) with videos related to
Sort By:
Page
of 42
Diabetes Research and Clinical Practice
|
January 15, 2022
Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study)
Annieke C G van Baar, Jacques Devière, David Hopkins, et al.
Gut
|
June 1, 2019
Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
Pieter de Groot, Torsten Scheithauer, Guido J Bakker, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 14, 2017
Individual and partner's level of occupation and the association with HbA<sub>1c</sub> levels in people with Type 2 diabetes mellitus: the Dutch Diabetes Pearl cohort
A Rutte, S P Rauh, M T Schram, et al.
Drugs - Real World Outcomes
|
March 22, 2022
Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer
Marscha S Holleman, Simone A Huygens, Maiwenn J Al, et al.
Clinical and Translational Gastroenterology
|
May 26, 2018
Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects
Kec Bouter, G J Bakker, E Levin, et al.
Gastroenterology
|
June 26, 2012
Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome
Anne Vrieze, Els Van Nood, Frits Holleman, et al.
Diabetologia
|
January 10, 2020
Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial
Pieter F de Groot, Tatjana Nikolic, Sultan Imangaliyev, et al.
Scientific Reports
|
October 23, 2020
Identifying genetic factors that contribute to the increased risk of congenital heart defects in infants with Down syndrome
Cristina E Trevino, Aaron M Holleman, Holly Corbitt, et al.
Journal of Hepatology
|
December 10, 2013
Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity
Anne Vrieze, Carolien Out, Susana Fuentes, et al.
Gut
|
October 27, 2020
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
Pieter de Groot, Tanja Nikolic, Silvia Pellegrini, et al.
Page
of 42